Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Breast Cancer

  Free Subscription


Articles published in Cancer Cell

Retrieve available abstracts of 18 articles:
HTML format
Text format



Single Articles


    May 2018
  1. CANOVAS B, Igea A, Sartori AA, Gomis RR, et al
    Targeting p38alpha Increases DNA Damage, Chromosome Instability, and the Anti-tumoral Response to Taxanes in Breast Cancer Cells.
    Cancer Cell. 2018 May 14. pii: S1535-6108(18)30181.
    PubMed     Text format     Abstract available


    February 2018
  2. LI CW, Lim SO, Chung EM, Kim YS, et al
    Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1.
    Cancer Cell. 2018;33:187-201.
    PubMed     Text format     Abstract available


  3. SALATINO M, Girotti MR, Rabinovich GA
    Glycans Pave the Way for Immunotherapy in Triple-Negative Breast Cancer.
    Cancer Cell. 2018;33:155-157.
    PubMed     Text format     Abstract available


  4. MCDONNELL DP, Norris JD, Chang CY
    Neomorphic ERalpha Mutations Drive Progression in Breast Cancer and Present a Challenge for New Drug Discovery.
    Cancer Cell. 2018;33:153-155.
    PubMed     Text format     Abstract available


  5. COSTA A, Kieffer Y, Scholer-Dahirel A, Pelon F, et al
    Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer.
    Cancer Cell. 2018 Feb 12. pii: S1535-6108(18)30011.
    PubMed     Text format     Abstract available


    January 2018
  6. DE MINGO PULIDO A, Gardner A, Hiebler S, Soliman H, et al
    TIM-3 Regulates CD103(+) Dendritic Cell Function and Response to Chemotherapy in Breast Cancer.
    Cancer Cell. 2018;33:60-74.
    PubMed     Text format     Abstract available


    November 2017
  7. PALAZON A, Tyrakis PA, Macias D, Velica P, et al
    An HIF-1alpha/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression.
    Cancer Cell. 2017;32:669-683.
    PubMed     Text format     Abstract available


    October 2017
  8. GULLUNI F, Martini M, De Santis MC, Campa CC, et al
    Mitotic Spindle Assembly and Genomic Stability in Breast Cancer Require PI3K-C2alpha Scaffolding Function.
    Cancer Cell. 2017;32:444-459.
    PubMed     Text format     Abstract available


  9. ROBERTS KJ, Kershner AM, Beachy PA
    The Stromal Niche for Epithelial Stem Cells: A Template for Regeneration and a Brake on Malignancy.
    Cancer Cell. 2017;32:404-410.
    PubMed     Text format     Abstract available


    August 2017
  10. YATES LR, Knappskog S, Wedge D, Farmery JHR, et al
    Genomic Evolution of Breast Cancer Metastasis and Relapse.
    Cancer Cell. 2017;32:169-184.
    PubMed     Text format     Abstract available


  11. ZHAO X, Powers S
    New Views into the Genetic Landscape of Metastatic Breast Cancer.
    Cancer Cell. 2017;32:131-133.
    PubMed     Text format     Abstract available


    April 2017
  12. HYDBRING P, Wang Y, Fassl A, Li X, et al
    Cell-Cycle-Targeting MicroRNAs as Therapeutic Tools against Refractory Cancers.
    Cancer Cell. 2017;31:576-590.
    PubMed     Text format     Abstract available


    October 2016
  13. SHAN L, Zhou X, Liu X, Wang Y, et al
    FOXK2 Elicits Massive Transcription Repression and Suppresses the Hypoxic Response and Breast Cancer Carcinogenesis.
    Cancer Cell. 2016 Oct 14. pii: S1535-6108(16)30445.
    PubMed     Text format     Abstract available


    September 2016
  14. ZENG H, Qu J, Jin N, Xu J, et al
    Feedback Activation of Leukemia Inhibitory Factor Receptor Limits Response to Histone Deacetylase Inhibitors in Breast Cancer.
    Cancer Cell. 2016;30:459-73.
    PubMed     Text format     Abstract available


    March 2016
  15. HALBERG N, Sengelaub CA, Navrazhina K, Molina H, et al
    PITPNC1 Recruits RAB1B to the Golgi Network to Drive Malignant Secretion.
    Cancer Cell. 2016;29:339-53.
    PubMed     Text format     Abstract available


  16. JING H, Hu J, He B, Negron Abril YL, et al
    A SIRT2-Selective Inhibitor Promotes c-Myc Oncoprotein Degradation and Exhibits Broad Anticancer Activity.
    Cancer Cell. 2016;29:297-310.
    PubMed     Text format     Abstract available


  17. GOEL S, Wang Q, Watt AC, Tolaney SM, et al
    Overcoming Therapeutic Resistance in HER2-Positive Breast Cancers with CDK4/6 Inhibitors.
    Cancer Cell. 2016;29:255-69.
    PubMed     Text format     Abstract available


    January 2016
  18. LI JY, Perry SR, Muniz-Medina V, Wang X, et al
    A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy.
    Cancer Cell. 2016;29:117-29.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: